A Near-infrared Turn-on Fluorescent Sensor for Sensitive and Specific Detection of Albumin from Urine Samples

A readily synthesizable fluorescent probe DMAT-π-CAP was evaluated for sensitive and selective detection of human serum albumin (HSA). DMAT-π-CAP showed selective turn-on fluorescence at 730 nm in the presence of HSA with more than 720-fold enhancement in emission intensity ([DMAT-π-CAP] = 10 μM), and rapid detection of HSA was accomplished in 3 s. The fluorescence intensity of DMAT-π-CAP was shown to increase in HSA concentration-dependent manner (Kd = 15.4 ± 3.3 μM), and the limit of detection of DMAT-π-CAP was determined to be 10.9 nM (0.72 mg/L). The 1:1 stoichiometry between DMAT-π-CAP and HSA was determined, and the displacement assay revealed that DMAT-π-CAP competes with hemin for the unique binding site, which rarely accommodates drugs and endogenous compounds. Based on the HSA-selective turn-on NIR fluorescence property as well as the unique binding site, DMAT-π-CAP was anticipated to serve as a fluorescence sensor for quantitative detection of the HSA level in biological samples with minimized background interference. Thus, urine samples were directly analyzed by DMAT-π-CAP to assess albumin levels, and the results were comparable to those obtained from immunoassay. The similar sensitivity and specificity to the immunoassay along with the simple, cost-effective, and fast detection of HSA warrants practical application of the NIR fluorescent albumin sensor, DMAT-π-CAP, in the analysis of albumin levels in various biological environments.

[1]  O. Wolfbeis,et al.  Microalbuminuria and borderline-increased albumin excretion determined with a centrifugal analyzer and the Albumin Blue 580 fluorescence assay. , 1997, Clinical chemistry.

[2]  G. Sudlow,et al.  Further characterization of specific drug binding sites on human serum albumin. , 1976, Molecular pharmacology.

[3]  Min Zhang,et al.  Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins* , 2002, The Journal of Biological Chemistry.

[4]  Pierre Ambrosi,et al.  Human serum albumin in the clinical syndrome of heart failure. , 2011, Journal of cardiac failure.

[5]  David G Levitt,et al.  Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states , 2017, Clinical and experimental gastroenterology.

[6]  Dong Joon Kim,et al.  A rapid, simple measurement of human albumin in whole blood using a fluorescence immunoassay (I). , 2004, Clinica chimica acta; international journal of clinical chemistry.

[7]  Dvm Elisa M. Mazzaferro Ms,et al.  The role of albumin replacement in the critically ill veterinary patient , 2002 .

[8]  M. Hariharan,et al.  Site-selective binding and dual mode recognition of serum albumin by a squaraine dye. , 2006, Journal of the American Chemical Society.

[9]  S. Curry,et al.  Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.

[10]  Wen Sun,et al.  A fluorescent probe for site I binding and sensitive discrimination of HSA from BSA. , 2014, Chemical communications.

[11]  Inger Sandlie,et al.  Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics , 2015, Front. Immunol..

[12]  J P Doweiko,et al.  The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[13]  Ying-Yi Wu,et al.  A selective and sensitive fluorescent albumin probe for the determination of urinary albumin. , 2014, Chemical communications.

[14]  S. Curry,et al.  Crystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXα , 2008, Journal of molecular biology.

[15]  Woong Jung,et al.  A Novel Probe with a Chlorinated α-Cyanoacetophenone Acceptor Moiety Shows Near-Infrared Fluorescence Specific for Tau Fibrils. , 2017, Chemical & pharmaceutical bulletin.

[16]  Jae Wook Lee,et al.  Combinatorial dapoxyl dye library and its application to site selective probe for human serum albumin. , 2007, Journal of combinatorial chemistry.

[17]  G. Sudlow,et al.  The characterization of two specific drug binding sites on human serum albumin. , 1975, Molecular pharmacology.

[18]  Eishun Tsuchida,et al.  BMC Structural Biology BioMed Central , 2003 .

[19]  T. Larson,et al.  Comparison of urinary albumin quantification by immunoturbidimetry, competitive immunoassay, and protein-cleavage liquid chromatography-tandem mass spectrometry. , 2009, Clinical chemistry.

[20]  David G Levitt,et al.  Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements , 2016, International journal of general medicine.

[21]  Marc Vendrell,et al.  Fluorescent dye cocktail for multiplex drug-site mapping on human serum albumin. , 2013, ACS combinatorial science.

[22]  Toru Maruyama,et al.  Albumin-drug interaction and its clinical implication. , 2013, Biochimica et biophysica acta.

[23]  K. Lau,et al.  Measurement of urine albumin using bromocresol green. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[24]  I. Dibirdik,et al.  The development and validation of a competitive, microtiter plate enzymeimmunoassay for human albumin in urine. , 1995, Journal of immunoassay.

[25]  G. Martin,et al.  Albumin: Biochemical properties and therapeutic potential , 2005, Hepatology.

[26]  Subramanyam Vemulpad,et al.  Distinctive autofluorescence of urine samples from individuals with bacteriuria compared with normals. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[27]  Ben Zhong Tang,et al.  Quantitation, visualization, and monitoring of conformational transitions of human serum albumin by a tetraphenylethene derivative with aggregation-induced emission characteristics. , 2010, Analytical chemistry.

[28]  Manoj Kumar,et al.  A TICT based NIR-fluorescent probe for human serum albumin: a pre-clinical diagnosis in blood serum. , 2016, Chemical communications.

[29]  J. Doweiko,et al.  Reviews: The Role of Albumin in Human Physiology and Pathophysiology, Part III: Albumin and Disease States , 1991 .

[30]  Poul Nissen,et al.  Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin. , 2010, Journal of structural biology.

[31]  Thimmaiah Govindaraju,et al.  A red-NIR emissive probe for the selective detection of albumin in urine samples and live cells. , 2017, Organic & biomolecular chemistry.

[32]  Bin Tong,et al.  Quantitation of Albumin in Serum Using "Turn-on" Fluorescent Probe with Aggregation-Enhanced Emission Characteristics. , 2015, ACS Applied Materials and Interfaces.

[33]  Renato Marchesini,et al.  Colorectal cancer detection by means of optical fluoroscopy. A study on 494 subjects. , 2010, Frontiers in bioscience.

[34]  S. Cummings,et al.  Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.